CoChat

Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial

Open access
Begtrup, Luise Mølenberg, de Muckadell, Ove B Schaffalitzky, Kjeldsen, Jens, Christensen, René dePont, Jarbøl, Dorte Ejg · 2013 · Scandinavian Journal of Gastroenterology
Cited by 84

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

OBJECTIVE. Meta-analyses have indicated effect of probiotics on irritable bowel syndrome (IBS). However, few long-term trials have been conducted and uncertainty remains as to effectiveness and long-term effect in a primary care setting. We aimed to investigate the effect of probiotics compared with placebo in the management of IBS in primary care during a 6-month treatment period and with a 6-month follow-up. MATERIAL AND METHODS. We randomized IBS patients fulfilling Rome III criteria to receive two capsules twice daily either containing placebo or a probiotic mixture of Lactobacillus paracasei ssp paracasei F19, Lactobacillus acidophilus La5 and Bifidobacterium Bb12 in an amount of 1.3 × 10(10) CFU per capsule. Primary endpoint was proportion of responders defined as patients reporting adequate relief (AR) at least 50% of the time in the 6-month treatment period. Secondary outcomes were proportions of patients reporting AR at different time points, and change in gastrointestinal symptoms and health-related quality of life (HrQOL) from baseline to 6 and 12 months. RESULTS. A total of 131 patients were included in this study. The proportion of responders in the treatment period was 52% (35/67) in the probiotic group versus 41% (26/64) in the placebo group, p = 0.18. Overall we found no difference between the groups in change in gastrointestinal symptoms after treatment. Patients improved in HrQOL, but with no statistically significant difference between the groups. CONCLUSION. During a 6-month treatment period, we were not able to detect a positive effect of probiotic when compared with placebo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/00365521.2013.825314

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 10

  1. 10.1007/s11894-012-0284-2 · DOI
  2. 10.1016/j.cgh.2012.12.038 · DOI
  3. 10.1111/j.1365-2036.2010.04239.x · DOI · Paper page
  4. 10.1038/ajg.2013.15 · DOI · Paper page
  5. 10.1053/j.gastro.2009.08.047 · DOI · Paper page
  6. 10.1111/j.1572-0241.2003.07158.x · DOI · Paper page
  7. 10.1016/j.cgh.2007.03.004 · DOI
  8. 10.1111/j.1572-0241.2006.00535.x · DOI · Paper page
  9. 10.1038/ajg.2009.13 · DOI · Paper page
  10. 10.1017/S109285290001436X · DOI · Paper page

Cited by

See all 84

Metadata

Authors
Begtrup, L. M., de Muckadell, O. B. S., Kjeldsen, J., Christensen, R. D., & Jarbøl, D. E.
Venue
Scandinavian Journal of Gastroenterology
Published
2013-08-19
Volume
48
Issue
10
Pages
1127-1135
ISSN
  • 0036-5521 (ISSN-L)
  • 1502-7708
OpenAlex
W2046984987
Cited by
84
References
18
FWCI
5.02
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial. https://app.cochat.ai/papers/10.3109/00365521.2013.825314
The paper
Begtrup, L. M., de Muckadell, O. B. S., Kjeldsen, J., Christensen, R. D., & Jarbøl, D. E. (2013). Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365521.2013.825314

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.